Ventus Therapeutics Begins Phase 1 Trial of Neuroinflammation Treatment
By Exec Edge Editorial Staff Ventus Therapeutics said it initiated Phase 1 testing for VENT-02,...
By Exec Edge Editorial Staff Ventus Therapeutics said it initiated Phase 1 testing for VENT-02,...
Sempra Vice President of Investor Relations Glen Donovan By Exec Edge Editorial Sempra (NYSE:SRE), a...
By Daniella Parra Comera Life Sciences Holdings (Nasdaq: CMRA) said it published data showing caffeine’s...
By Daniella Parra Avertix Medical said it was collaborating with the Heart & Rhythm Institute...
By Daniella Parra Sparrow Pharmaceuticals said it was extending the trial phase for SPI-62, a...
GigaCloud Technology Inc. (Nasdaq: GCT), said revenue rose 23.5% to $153.1 million in the second...
By Daniella Parra TechMet said it closed its latest $200 million equity fundraising round and...
By Daniella Parra On Holding AG (NYSE: ONON) said it was raising its outlook for...
By Daniella Parra Grove Collaborative Holdings, Inc. (NYSE: GROV) said Jeff Yurcisin was appointed as...
By Daniella Parra AvePoint (NASDAQ: AVPT) said second quarter revenue rose 16 percent to $64.9...